Press Releases
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY
Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s...
Press Releases
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being released today so that vaccinations may begin early in the New Year.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided...
Packaging & Labelling
FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States
FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, announced that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States.
Following the Food and Drug Administration’s...
Clinical Trials
Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19
Vir Biotechnology, Inc. announced that the first patient has been dosed in a new sub-trial of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program Phase 3 clinical trial. This trial is designed to...
Packaging & Labelling
Pelican BioThermal Announces Korean Air Cargo Partnership
Pelican BioThermal, the global name in temperature controlled packaging, announces its new partnership with Korean Air Cargo, the latest in the company’s expanding network of worldwide alliances.
The significant new partnership will see the Asia airline utilize Pelican BioThermal’s Cr?do™...
Press Releases
Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the U.S. FDA has authorized the emergency use of mRNA-1273, Moderna’s vaccine against COVID-19 in individuals 18 years of age or older. The Moderna COVID-19...
Drug Research
Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing
Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read